Government as the First Investor in Biopharmaceutical Innovation

Using data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at Bentley University published a paper investigating the involvement of government funding in recently approved drugs. They focused on the 356 new drugs approved by the U.S. Food and Drug Administration from 2010-2019 and found: Research […] Source